Company: LGN
Filing Date: 2025-02-14
Form Type: DRS
Source: 0000950123-25-002471
Chunk: 160

Company: Legence Corp.
Filing Date: 2025-02-14
Form: DRS
Chunk 160
---
 of directors; develop and oversee our internal
corporate governance processes and maintain a management succession plan. We have adopted a nominating and corporate governance committee charter to be effective upon the completion of this offering defining the committee’s primary duties in a
manner consistent with the rules of the SEC and the listing standards of the .

Compensation Committee Interlocks and Insider Participation

None of our executive officers serve on the board of directors or compensation committee of another public
company that has an executive officer that serves on our board of directors or compensation committee. No member of our board of directors is an executive officer of another public company in which one of our executive officers serves as a member of
the board of directors or compensation committee of that company.

Code of Business Conduct and Ethics

Prior to the completion of this offering, our board of directors will adopt a code of business conduct and ethics applicable to our employees,
directors and officers that will comply with applicable U.S. federal securities laws and the corporate governance rules of the . Any waiver of this code may be made only by our board of directors and will be promptly
disclosed as required by applicable U.S. federal securities laws and the corporate governance rules of the .

Corporate Governance Guidelines

Prior to the completion of this offering, our board of directors will adopt corporate governance guidelines
in accordance with the corporate governance rules of the .

110

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 COMPENSATION DISCUSSION AND ANALYSIS The purpose of this compensation discussion and analysis section is to provide information about the material elements of compensation that are paid, awarded to, or earned by, our “named executive officers,” who consist of our executive officers, including our principal executive officer and principal financial officer. For fiscal year 2024, our named executive officers were:

| • |     | Jeffrey Sprau, Chief Executive Officer and member of the Board of Managers of Legence Parent; |

| • |     | Stephen Butz, Chief Financial Officer; |

| • |     | Gregory Barnes, Chief Human Resources Officer; and |

| • |     | Bryce Seki, General Counsel. |

Historical Compensation Decisions Prior to this offering, we were a private company. As a result, the compensation awarded to, earned by, or paid to our directors and named executive officers for 2024 was provided by and determined in accordance with policies and practices developed by the Board of Managers of Legence Parent, in collaboration with the Chief Executive